Biotech · Private company · Providence, RI, US

Prothera Biologics, LLC

Track this companyFree. Adds Prothera Biologics, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing EnterocolitisFiscal year 2026 · $954.2KNIH RePORTER 5R44AI141283-06 · fetched Nov 12, 2026
Inter-alpha Inhibitors in Experimental Necrotizing EnterocolitisFiscal year 2025 · $50.2KNIH RePORTER 3R43HD114348-01S1 · fetched Nov 12, 2026
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing EnterocolitisFiscal year 2025 · $971.3KNIH RePORTER 5R44AI141283-05 · fetched Nov 12, 2026
Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing EnterocolitisFiscal year 2024 · $987.4KNIH RePORTER 2R44AI141283-04 · fetched Nov 12, 2026